Last reviewed · How we verify

NCT05625841: Mucositis

Effects for Oral Mucositis Care During Chemoradiotherapy in Cancer Patients: Evaluation of the Bee Products

Status unknown NA Last updated 23 November 2022
What this trial tests

NA trial testing Honey product in Oral Mucositis in 135 participants. Status unknown.

Timeline
25 November 2022
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorTaipei Medical University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingtriple
Primary purposeprevention
Enrollment135
Start date25 November 2022
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Taipei Medical University

Who can join

20 and older, any sex, with Oral Mucositis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Oral mucositis is common among cancer patients receiving radiotherapy and chemotherapy. 80-90% of the patients are suffering from the mucositis pain; poor nutrition and even treatment discontinued. Some self-paid medications like glutamine has been used to prevent mucositis before and during radiotherapy/chemotherapy. Randomized controlled trials have shown that honey and propolis may be used for the management of mucositis. Honey demonstrates the most significant antibacterial effects; the green propolis has also been proved to comprise antibacterial, anti-inflammatory, and antioxidant effects. Bee products have been concerned as potential sources of natural antioxidants such as flavonoids, phenolic acids, and terpenoids. This study plan to conduct an RCT comparing the effectiveness of honey, honey and green propolis, and usual care in mucositis of cancer patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Oral Mucositis

Currently open trials in the same condition.

Other Taipei Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05625841.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing